Investment
Features
FeesSafety
Academy
More
Pluang+

TPG RE Finance Trust trades 24% below book value, offers 11.5% dividend yield backed by strong earnings.

Market News
11 Jul 2026
Seeking Alpha
View Source
Bullish
pluang ai news

TPG RE Finance Trust (TRTX) is currently trading at a significant 24% discount to its book value per share, presenting a potential value opportunity for investors. The company continues to buy back stock at an accretive pace while paying an attractive 11.5% dividend yield, supported by a quarterly payout of $0.24 per share that is 104% covered by distributable earnings. Additionally, TRTX has grown its loan investment portfolio by 26.5% year-over-year, which should help maintain strong net interest income (NII). These factors suggest TRTX offers a safe yield and potential for long-term wealth creation despite its tepid stock price recovery.

More News

Upbit lists four new altcoins, ETHGas leads with an 11% price surge.

Upbit lists four new altcoins, ETHGas leads with an 11% price surge.

South Korea's Upbit exchange added four new altcoins—ETHGas (GWEI), Biconomy (BICO), Bubblemaps (BMT), and Nillion (NIL)—with trading pairs in BTC and USDT. ETHGas saw the biggest immediate price jump of about 11%, while the others rose over 7%. Trad...

Market News
Bullish
4 hours ago
Guident secures 36-month robotic monitoring deal with Coastal Waste, expanding AI-powered inspections.

Guident secures 36-month robotic monitoring deal with Coastal Waste, expanding AI-powered inspections.

Tekcapital's portfolio company Guident has signed a 36-month agreement with Coastal Waste & Recycling to deploy its WatchBot autonomous inspection robots and AI software across more than 40 Coastal locations. The system will conduct facility patrols,...

Market News
Bullish
4 hours ago
Corcept Therapeutics rated Strong Buy with 44% revenue growth and key FDA decisions ahead

Corcept Therapeutics rated Strong Buy with 44% revenue growth and key FDA decisions ahead

Corcept Therapeutics is rated Strong Buy with price targets of $163 in one year and $222 in two years, driven by rapid revenue and margin growth. The company’s new drug Lifyorli is launching quickly for platinum-resistant ovarian cancer, and Korlym c...

Analyst Insights
Bullish
4 hours ago
Pop Mart shares fall over 4% after weaker-than-expected H1 sales, especially outside China

Pop Mart shares fall over 4% after weaker-than-expected H1 sales, especially outside China

Pop Mart's shares dropped more than 4% after it reported first-half revenue of 17.17 billion yuan, up 23.8% year-over-year but below expectations due to declines in Asia Pacific (excluding China) and the Americas. Revenue in China grew 47.3%, but sal...

Company Fundamentals
Bearish
4 hours ago
Bitcoin briefly rose above Strategy's $75,385 cost, yielding $192M unrealized gain before price shifted again.

Bitcoin briefly rose above Strategy's $75,385 cost, yielding $192M unrealized gain before price shifted again.

Strategy holds 840,447 Bitcoin with an average acquisition cost of $75,385 per coin. On August 21, Bitcoin's price briefly climbed above this cost during an 8.5% daily rally, generating an estimated unrealized gain of about $192 million before prices...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App